DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Moss RB, Flume PA, Elborn JS et al.
Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial.
Lancet Respir Med 2015;
3: 524-533
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.